The Centers for Medicare and Medicaid Services estimates U.S. health care spending will grow 5.6% annually through 2032, ...

Novo Nordisk is licensing a drug called LX9851 from Lexicon Pharmaceuticals for up to $75 million in upfront and near-term ...

A multicenter study led by Cedars-Sinai created a database of adverse medication events—the fourth leading cause of death in ...

Some patients say that with research and persistence, they’ve been able to make price transparency work for them.

(“BioSyent”, TSX Venture: RX) is pleased to announce that FeraMAX ® is the #1 recommended iron supplement brand in Canada, based on a national survey of Canadian pharmacists and physicians (1). This ...